NewslettersHuman Immunology News Immunotherapy Drives Mesenchymal Tumor Cell State Shift and TME Immune Response in Glioblastoma Patients By lbeveridge - May 6, 2024 0 Investigators present the integrative paired single-cell RNA-seq analysis of 76 tumor samples from patients in a clinical trial of the PD-1 inhibitor nivolumab and untreated patients. [Neuro-Oncology] AbstractGraphical Abstract